Press releases
-
08/09/2010
Almirall awarded the “zero rate” for accident frequency in 2009
The pharmaceutical company has been awarded the COASHIQ award for reducing its accident...
-
30/07/2010
First Half 2010 in line with guidance, strong R&D catalysts expected in second half
See attached .pdf
More Press releases
- 28/07/2010 Sativex® receives regulatory authorisation in Spain
- 26/07/2010 Almirall signs a co-promotion agreement with Pfizer to commercialise Conbriza® in Spain, a new therapeutic option to treat osteoporosis
- 23/07/2010 Almirall reaffirms its commitment to the environment with renewal of its ISO 14001:2004 certificate
- 17/06/2010 The presentation of the Neogenius project brings together around a hundred investigators
- 15/06/2010 Almirall announces an international agreement with Basilea to commercialize Toctino® (alitretinoin) for severe chronic hand eczema
Optimized for Internet Explorer